Vistagen Appoints Nick Tressler as New CFO, Effective December 1, 2025.

miércoles, 3 de diciembre de 2025, 4:51 pm ET1 min de lectura
VTGN--

Vistagen, a late clinical-stage biopharmaceutical company, has appointed Nick Tressler as its new Chief Financial Officer (CFO). Tressler brings extensive experience in the biopharmaceutical industry, and his appointment is expected to accelerate the company's next phase. He will be responsible for financial and strategic planning, and his expertise will be instrumental in the company's growth.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios